The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial

2015 ◽  
Vol 19 (5) ◽  
pp. 867-877 ◽  
Author(s):  
Satoru Muto ◽  
Haruna Kawano ◽  
Eiji Higashihara ◽  
Ichiei Narita ◽  
Yoshifumi Ubara ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document